Advertisement
U.S. markets closed

TNF Pharmaceuticals, Inc. (TNFA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.3400+0.0200 (+1.52%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.69M
Enterprise Value -6.51M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.22
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.67
52-Week Change 3-85.31%
S&P500 52-Week Change 331.18%
52 Week High 310.6800
52 Week Low 31.1200
50-Day Moving Average 31.4597
200-Day Moving Average 32.1162

Share Statistics

Avg Vol (3 month) 334.14k
Avg Vol (10 day) 339.35k
Shares Outstanding 52.76M
Implied Shares Outstanding 62.76M
Float 82M
% Held by Insiders 15.12%
% Held by Institutions 144.10%
Shares Short (Oct 31, 2024) 4267.35k
Short Ratio (Oct 31, 2024) 46.39
Short % of Float (Oct 31, 2024) 410.85%
Short % of Shares Outstanding (Oct 31, 2024) 49.70%
Shares Short (prior month Sep 30, 2024) 4243.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 25, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Feb 15, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.43%
Return on Equity (ttm)-297.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-23.35M
Diluted EPS (ttm)-13.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.07M
Total Cash Per Share (mrq)5.51
Total Debt (mrq)25.8k
Total Debt/Equity (mrq)6.75%
Current Ratio (mrq)2.48
Book Value Per Share (mrq)6.05

Cash Flow Statement

Operating Cash Flow (ttm)-9.67M
Levered Free Cash Flow (ttm)-2.49M